Intech Biopharm Corporation (TPEX:6461)
19.20
+0.05 (0.26%)
Aug 15, 2025, 1:30 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 3.13 billion as of August 15, 2025. Its market cap has decreased by -23.98% in one year.
Market Cap
3.13B
Enterprise Value
4.10B
Revenue
115.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.20
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 3.13B, a decrease of -21.88%. That is a compound annual growth rate of -2.20%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Caliway Biopharmaceuticals | 208.61B |
PharmaEssentia | 169.30B |
Bora Pharmaceuticals Co., LTD. | 94.94B |
Lotus Pharmaceutical | 53.91B |
Oneness Biotech | 32.23B |
Polaris Group | 27.62B |
Lumosa Therapeutics | 27.18B |
Center Laboratories | 26.85B |